The concordance of the results within the allograft or the GEMM autochthonous tumor samples and models suggests that Resf1 may have diametrically opposite effects on primary tumor growth and metastatic disease, as has been observed for TGFβ. This evidence concerns the gene RESF1 and neoplasm.